Meghna Mehta
Gaithersburg,MD
Summary
A versatile biopharma commercial leader highly proficient in brand strategies, launching products in new & complex markets and driving high-impact promotional programs. Proven track record in leading launch teams, leadership presentations and successfully managing external alliances. An energetic, committed, and inclusive leader that inspires teams to achieve key forecast & performance goals for brands.
Everyday work philosophy: Lead | Create | Collaborate
Overview
24
24
years of professional experience
Work History
Global Marketing Director, IO Lung
AstraZeneca
12.2021 - Current
- Resectable NSCLC
-Brand Strategy & launch readiness: Built competitive brand strategy for IMFINZI, successfully positioned IMFINZI to win in highly competitive market. Directed global cross-functional team to deliver on the launch including multiple OBULT leadership presentations. Provided strategic inputs to ensure competitive labels. Proactively collaborated with commercial leaders from G8 countries via series of launch activation workshops, 5-day immersive KEE led clinical program to a ensure aligned execution of global launch
-Innovative promotional programs: Developed and executed a global promotional campaign, including CVA, message platform and strategic assets for a successful launch. Designed a unique program “Optimize Every Move” to engage HCPs & patients to prevent patient drop-off pre-/post-surgery.
-Market Shaping: Partnered with 10+ leading KEEs to develop a signature unbranded education program “Adopting Perioperative excellence (APEX)” aimed to solidify AZ scientific leadership in early-stage NSCLC.
• Stg I-II unresectable NSCLC: Leading PACIFIC-4 ($850M PYS) launch plans to expand IMFINZI in early-stage NSCLC. Drive launch brand strategy, market shaping, pre-HLR scenario plan to prepare for successful launch - Designed impactful promotional materials that effectively communicated key product benefits to target audiences.
Sr. Global Brand Director
Gilead Sciences, Inc.
01.2018 - 01.2021
- Global Brand Strategy & Launch Readiness (NASH - Ph3): Led launch teams to develop comprehensive global brand strategy & market development initiatives in a new disease area (NASH). Directed a category leading disease state campaign, “NASH360”, cementing the critical unmet needs in this space. Crafted a differentiated global brand positioning, messaging & launch campaign, drove congress booth / presence. Designed operating plans for two alliances in liver diagnostics space (Siemens & Echosens), catalyzing overall TA strategy.
- Rare Disease Commercial Strategy (PSC - Ph3): Directed an integrated pre-launch global commercial strategy plan for a novel drug (~$1B). Orchestrated key market shaping activities, including KOL expert committees, disease state campaigns, patient advocacy activation. Drove strategic launch initiatives including early positioning, brand & trial naming, launch country prioritization, packaging strategy & life-cycle planning
- VEMLIDY LCM Strategy (Hepatitis B brand): Championed a holistic life-cycle plan for VEMLIDY, driving double-digit growth for this ~$500M chronic HBV brand.
Global Strategy & Ops Director
EMD Serono, Merck KgaA
01.2017 - 01.2018
- Franchise Commercial Operations: Led global annual brand planning with regions for a $2B+ portfolio.
- Worked with finance for long-range forecasts and provided P&L oversighDeveloped ASCO congress strategy, internal website and tactical plan
- Streamlined target product claims and profile development process for the pipeline assets
US Commercial - IO Brand Insights Leader
AstraZeneca Pharmaceuticals
01.2014 - 01.2017
- US Commercial Brand Insights for IMFINZI: Conducted in-depth market research to craft compelling brand positioning & messaging in HNSCC, Mesothelioma & NSCLC, strategically guiding CVA for IMFINZI.
- US Commercial Promotional Program Insights: Supported comprehensive research initiatives to enhance franchise marketing programs for patients, physicians, and nurses. Collaborated with brand teams and ACCESS360 teams to develop LIGHTHOUSE patient support program & creative patient-centric access solutions (e.g., AMAZON button – a unique call center service feature that differentiated ACCESS360)
- US IO Franchise Planning: Delivered actionable insights that fueled the launch of first IO franchise launch plan across multiple tumor types. Collaborated cross-functionally to develop targeted customer segmentation, optimized sales force sizing.
Sr. Manager, US Business Development
AstraZeneca Pharmaceuticals
01.2009 - 01.2013
- US Oncology Portfolio Expansion: Secured buy-in and executed a synthetic growth strategy, lead holistic commercial evaluations for 30+ external assets in diverse therapeutic areas.
- US Distribution Strategy for AZD6765: Developed a comprehensive distribution channel strategy for this Ph2b psychiatry program paving the way for commercialization.
Sr. Manager, Diagnostics Business Development
Johnson & Johnson
01.2008 - 01.2009
- Diabetes Diagnostics Growth Strategy: Engineered a cutting-edge business growth strategy, spearheading an equity deal with S4MS for a novel minimally invasive diabetes diagnostics, successfully orchestrating a $35M investment
Sr. Manager, Business Development
Anesiva, Inc.
01.2007 - 01.2008
- Early Pipeline Program Leadership: Directed a sub-team that identified and developed two breakthrough programs within a drug-device combination technology platform, creating significant growth upside.
- Business Development Initiatives: Developed a comprehensive business growth roadmap and licensing strategy. Effectively engaged with internal & external stakeholders, contributing to the successful $114M out-licensing deal for Ph1 asset and two marketed products in China, Canada, Middle East and Eastern Europe
Manager, Commercial Strategy & Business Development
CTI Biopharma
01.2007 - 01.2008
- HemOnc Pipeline Commercialization: Provided commercial guidance to R&D for Phase 2/3 investments in hematological indications for Pixantrone (Pixuvri) resulting in life-cycle mgmt. l investments for these assets.
- Late-Stage Licensing Deal: Supported the commercial case for an out-licensing deal with Novartis Oncology, securing a $300M investment.
US Forecasting Lead, New Product Launches
Sunovion, Inc.
01.2005 - 01.2006
- Forecasting for $1B portfolio: Developed and managed short, medium, and long-term forecasts for Lunesta and Xopenex HFA
- Established a robust platform for launch forecasting
Brand Manager
Alembic Pharmaceuticals
01.2001 - 01.2002
- Driving brand sales and marketing: Managed sales and marketing for a 5-product portfolio in India.
- Developed strong customer base and achieved 120% target sales, by managing sales team of 3 sales representatives in India
Education
Master of Business Administration -
Rutgers Business School
Newark, NJBachelor of Pharmacy -
S.P. University
Skills
- Driving internal and external collaborations
- Influencing and motivating teams
- Nurturing creativity to solve complex problems
- Learning agility and flexibility to adapt to change
Timeline
Global Marketing Director, IO Lung
AstraZeneca
12.2021 - Current
Sr. Global Brand Director
Gilead Sciences, Inc.
01.2018 - 01.2021
Global Strategy & Ops Director
EMD Serono, Merck KgaA
01.2017 - 01.2018
US Commercial - IO Brand Insights Leader
AstraZeneca Pharmaceuticals
01.2014 - 01.2017
Sr. Manager, US Business Development
AstraZeneca Pharmaceuticals
01.2009 - 01.2013
Sr. Manager, Diagnostics Business Development
Johnson & Johnson
01.2008 - 01.2009
Sr. Manager, Business Development
Anesiva, Inc.
01.2007 - 01.2008
Manager, Commercial Strategy & Business Development
CTI Biopharma
01.2007 - 01.2008
US Forecasting Lead, New Product Launches
Sunovion, Inc.
01.2005 - 01.2006
Brand Manager
Alembic Pharmaceuticals
01.2001 - 01.2002
Bachelor of Pharmacy -
S.P. University
Master of Business Administration -
Rutgers Business School
Similar Profiles
Jasmine JohnsJasmine Johns
Project Management Associate (Medical Affairs) at AstraZenecaProject Management Associate (Medical Affairs) at AstraZeneca
Courtlyn WheelerCourtlyn Wheeler
Pharmaceutical Sales Specialist at AstraZenecaPharmaceutical Sales Specialist at AstraZeneca
Liliana Acosta JohnsonLiliana Acosta Johnson
Cyber Security Assurance Manager at AstraZenecaCyber Security Assurance Manager at AstraZeneca